HealtHcare
Minister of Health in the Government of the Republic of Serbia
CALL FOR COLLECTIVE ACTION ON MENTAL HEALTH AND EMPATHY
PROF. DR. FABIO SKANO Director of the World Health Organization (WHO) in Serbia
At the mental health conference in Serbia, Mr. Stano, a representative of the World Health Organization (WHO), delivered a speech that emphasized both the historical and contemporary relevance of mental health. He began by taking the audience back to 1948, the founding year of the WHO, when its constitution declared that “health is a state of complete physical, mental, and social well-being, and not merely the absence of disease.” Stano noted how visionary this definition was, especially coming from a generation that had survived World War II and understood the profound effects of crises on mental well-being.
Fast-forwarding to the present day, Stano pointed out that although 76 years have passed, progress in mental health remains slow, mainly due to ongoing stigma and discrimination. However, he cited the COVID-19 pandemic as a turning point, bringing mental health into sharper focus for many, along with other global crises, including the recent tragic events in Serbia.
Stano emphasized the growing political commitment to mental health worldwide, citing the example of France, where mental health has become a government priority. Closer to home, he praised the efforts of the six ministries in Serbia,
WHO’s Mr. Stano Highlights the Importance of Mental Health and Collective Responsibility
which have joined forces to advance mental health care, in collaboration with UNICEF and other partners.
He highlighted the importance of taking a systemic approach to mental health, strengthening the capacity of the health system to recognize mental health conditions, especially in youth, and referring them to appropriate care when needed. A campaign supported by WHO, “Čuvaj sebe, ne čuvaj u sebi” (Take care of yourself, don’t keep it inside), has already made an impact in Serbia, and further efforts are planned to improve mental health services for young people.
Stano also touched on the growing concern about the impact of social media and screen time on children. He shared a personal story about his own children and the challenges of managing their exposure to technology, referencing a recent WHO report that found one in eleven children in Serbia spends more than seven hours a day on social media and the internet. He stressed the importance of open discussions with children about screen time and its effects.
MENTAL HEALTH
DE-STIGMATIZATION BEGINS WITH OUR OWN APPROACH
On a personal level, Stano encouraged everyone to cultivate empathy and to teach children the importance of reaching out to others. He emphasized that while individuals don’t need to be doctors for their friends, they should be aware of when to refer someone for professional help. He closed by reminding the audience that tackling the stigma around mental health starts with each individual and the way they approach the topic in their daily lives.
“Above all, this is a lesson we must also apply to ourselves,” he said. “Mental health de-stigmatization begins with our own approach.”
Stano’s speech served as a powerful reminder that mental health is everyone’s responsibility, requiring both systemic action and personal empathy to create lasting change.
DR. ZLATIBOR LONČAR
Minister of Health in the Government of the Republic of Serbia
Born on 3 August 1971 in Belgrade, Dr. Lončar graduated from the Belgrade University Medical School in 1996/97, specializing in general surgery in 2003. He completed advanced training in hepatobiliary and transplantation surgery in London and Zagreb. He holds a PhD in medical epidemiology, defended in 2015.
Dr. Lončar has held various leadership roles at the Clinical Centre of Serbia, including Director of the Emergency
Centre and Head of the Transplantation Department. He led the team that performed the first liver transplant at the Emergency Centre. His efforts also contributed to establishing multiple medical departments and procuring essential equipment for the Emergency Centre.
Dr. Lončar served as Minister of Health of the Republic of Serbia from 2014 to 2022, and was reappointed to the same position on 2 May 2024.
COLLECTIVE ACTION ON CHILD AND YOUTH HEALTH
Government Focuses on Expanding Health Services and Intersectoral Collaboration to Protect Future Generations
At a recent mental health conference, Minister of Health Zlatibor Lončar addressed distinguished guests, colleagues, and partners, emphasizing the importance of a collective approach to ensuring the health and well-being of Serbia’s children and youth. He expressed the government’s commitment to “health for all”, stating that children and young people, as future leaders, are one of the country’s top priorities.
Minister Lončar highlighted the Ministry of Health’s efforts in recent years, particularly in expanding the network of services dedicated to protecting the health of children and adolescents. He underscored that the ministry’s actions, in cooperation with other sectors such as education, social protection, and the Ministry of Youth and Tourism, are a clear reflection of their commitment to providing comprehensive and continuous care for young people.
He also stressed that the intersectoral collaboration supported by the government will yield the best results in promoting the well-being of children and youth. Partnerships with UNICEF and the World Health Organization (WHO) play a vital role in identifying community needs and reaching every child, adolescent, and caregiver.
Acknowledging the challenges of growing up, Minister Lončar noted that the transition from childhood to youth is one of the most demanding tasks in a person’s life. He reiterated that the promotion of mental health, prevention, and early intervention remain core activities of the Ministry of Health,
A HEALTHY SERBIA IS OUR COMMON GOAL, AND HEALTHY CHILDREN ARE OUR GREATEST AND MOST IMPORTANT INVESTMENT
which approaches health holistically—recognizing that “there is no health without mental health.”
Concluding his speech, Minister Lončar expressed his enthusiasm for future collaborations, stressing that “a healthy Serbia is our common goal, and healthy children are our greatest and most important investment.” He congratulated the organizers on the success of the conference and wished them continued progress in their vital work.
Minister Dr. Lončar at the UNICEF conference
UNICEF
The Ministry of Health continues its campaign of free preventive health check-ups, aimed at early disease prevention and diagnosis.
The check-ups will be available today from 8 a.m. to 5 p.m. in health institutions across the country. This weekend’s focus is on scanner examinations, with the goal of eliminating waiting lists by Monday.
In health institutions across Serbia, free preventive check-ups are available from 8 a.m. to 5 p.m.
Minister of Health Zlatibor Lončar stated on RTS 1 that special attention has been given to gastroenterology and hematology check-ups. He also announced that tumor marker tests will be conducted by the end of the year, urging all citizens over the age of 40 to take this test.
He stressed that the goal is to make Serbia a healthier nation, and preventive check-ups are just one of many measures aimed at achieving that goal.
Minister Lončar expressed confidence that after this weekend, there will no longer be waiting lists for scanner examinations and that citizens requiring scans in the coming period will only have to wait a few days.
At the University Clinical Centre of Serbia (UKCS) on Sunday, all citizens, including those without health insurance, will be able to undergo free preventive check-ups as part of the campaign organized by the Ministry of Health.
The check-ups will be conducted from 8 a.m. to 5 p.m. in the new building of the University Clinical Centre of Serbia, at the north entrance, from Kosta Todorović Street.
The Ministry of Health announced that citizens will have the opportunity to undergo check-ups with hematologists and gastroenterologists, as well as have their blood pressure measured and lab tests performed, including complete blood count, biochemistry, LDH, ferritin, iron levels, bilirubin, transaminases, and CRP. Tumor marker tests (CEA, CA 19-9, and optionally AFP) will also be available. No prior appointments are necessary.
Any patients showing irregularities during the examinations or in their test results will be immediately referred for further diagnostics and tests.
FREE PREVENTIVE HEALTH CHECK-UPS CONTINUE ACROSS SERBIA TO BOOST EARLY DISEASE DETECTION
The Ministry of Health Focuses on Eliminating Scanner Waiting Lists and Expanding Access to Critical Health Services
The Ministry of Health and the University Clinical Centre of Serbia encourage citizens to take advantage of this opportunity, participate in Sunday’s campaign, and positively impact their health through preventive check-ups.
At the University Clinical Centre of Vojvodina (UKCV), preventive check-ups will be conducted at the Specialist Polyclinic, where citizens will be able to undergo basic medical examinations, laboratory tests (complete blood count), biochemical analyses (CRP, LDH, ferritin, transaminases, bilirubin, iron levels, and tumor markers), as well as gastroenterology and hematology examinations.
MINISTER LONČAR EMPHASIZED THAT PREVENTIVE CHECK-UPS ARE A VITAL STEP TOWARDS CREATING A HEALTHIER SERBIA, URGING CITIZENS TO TAKE ADVANTAGE OF THESE FREE SERVICES
Health institutions are calling on all citizens to participate in these preventive check-ups and positively influence their health.
A list of health institutions participating in the campaign, along with detailed information on the types of check-ups available at each institution, can be found on the official website of the Ministry of Health.
ASTRAZENECA’S COMMITMENT TO HEALTHCARE IN SERBIA
Innovative solutions enhancing patient care and driving healthcare reforms
AstraZeneca has a strong presence in Serbia. Can you share how the company’s innovations in healthcare are specifically benefiting Serbian patients and the local healthcare system?
Let me start with the fact that AstraZeneca has been present in Serbia for more than 45 years and currently we are among the top innovative pharmaceutical companies in the country. In the last two years the team has doubled and now more than 100 professionals are dedicated to support Serbian healthcare system and patients. In other words, historically we are partnering with the local authorities sustainably and as of today we continue to be committed to contributing to healthcare reforms and improving patient outcomes in Serbia. Our focus is on increasing access to cutting-edge treatments and therapies for patients in the region. We work closely and day-to-day with healthcare professionals, regulatory authorities, and policymakers to ensure that innovative medicines are available to those who need them. We are supporting Serbian patients in several major therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory Diseases, as well as Vaccines & Immunology. Since 2022 we have also established our Rare Diseases unit and are already helping such patients and their families too.
Serbia is undergoing significant reforms in its healthcare system. How is AstraZeneca contributing to these efforts, particularly in areas like improving patient outcomes and access to cutting-edge treatments?
We are witnessing a wave of new therapeutic solutions that transform the outlook for patients in a positive direction. The share of the population over the age of 65 is increasing globally and Serbia isn’t an exception. Thus, there’s a significant increase in both chronic and oncological diseases. In partnership with country’s institutions, we are working towards changing the way of thinking about healthcare to meet society’s expectations. Health care spending, particularly for prevention, early diagnosis and access to innovative therapy, is a public investment, both in the well-being of citizens and in economic future. Better health leads to prosperity. Healthier people enjoy longer and more productive working lives and spend less on health care. Through our early access programs, we give Serbian patients the opportunity for free treatment with the company’s innovative products, which are not yet reimbursed by the healthcare system. As mentioned above, following the related regulations and in constant open dialogue with the institutions, we ensured access to treatment for patients with a number of oncological, cardiovascular, pulmonary, nephrological, rheumatological and rare diseases. On a global perspective, earlier this year we presented our „Ambition 2030” program, where we stated that we will launch 20 new medicines in that period.
And our local team is here to boost these new treatments to enter timely Serbia and ensure that the patients who need them to have the proper access to them.
The role of digital healthcare has grown in recent years. What is AstraZeneca doing to promote digital health solutions in Serbia, and how are these solutions helping to improve the early diagnosis and treatment of chronic diseases?
We recognize the growing importance of digital healthcare and here I can again build on global practices in this direction that we are implementing on local markets as well. Our big focus is on Data Analytics and AI to support analyzing large datasets for early disease detection and personalized treatment approaches. These technologies can help identify patterns and trends that contribute to early diagnosis and intervention for chronic diseases. This is why we are closely partnering with tech companies and startups. With their support we integrate digital health solutions into disease management. These
ASTRAZENECA HAS BEEN PRESENT IN SERBIA FOR MORE THAN 45 YEARS AND IS AMONG THE TOP INNOVATIVE PHARMACEUTICAL COMPANIES IN THE COUNTRY
KSENIJA PURKOVIĆ Cluster Director Balkans at AstraZeneca
collaborations could involve the use of wearable devices, telemedicine platforms, or data-driven insights to improve patient outcomes. Utilizing omnichannel campaigns we provide Serbian healthcare professionals with digital resources and training programs to enhance their understanding and application of digital health solutions in the early diagnosis and treatment of chronic diseases.
We are also very proud that for a second consecutive year we were hosting Health Hackathons in Serbia too, as part of Balkans HealthHackaton program. This is a project fully supported by AstraZeneca Balkans in collaboration with respective local partners and it aims to inspire and empower the next generation of healthcare innovators to foster new solutions. Over two days, students from biomedical, business, and technical backgrounds were tasked with devising practical solutions for real-world health challenges. Great projects were presented, and more than 30 students from Serbia took part in this year’s edition. Majority of them also joined our Balkans Internship program, showcasing high interest to develop their career in an innovative pharmaceutical company.
WE
WORK CLOSELY WITH HEALTHCARE PROFESSIONALS, REGULATORY AUTHORITIES, AND POLICYMAKERS
TO ENSURE THAT INNOVATIVE MEDICINES ARE AVAILABLE TO THOSE WHO NEED THEM
AstraZeneca has a strong global focus on sustainability. How does this commitment translate into concrete actions in Serbia, particularly in terms of promoting environmental sustainability and ensuring equitable access to medicines?
Collaboration between the private sector and public health institutions is key to advancing healthcare. Can you share any recent partnerships AstraZeneca has formed in Serbia to enhance healthcare services, research, or educational programs for healthcare professionals?
There are many projects that can be mentioned in this regard, but I can highlight few of them like Breast Cancer Policy shaping project that is developing in collaboration between the Ministry of Health, Swedish Embassy and Business of Sweden. As part of this partnership, in less than a month, a Breast Cancer Academy with Swedish experts will take place in Serbia. They will share knowledge and experience with our healthcare professionals and institutions on how to improve screening, early diagnostics, access to therapy and patient support programs.
In September 2023, together with the Serbian government we signed a Memorandum of Understanding confirming our participation in the Bio4 campus. This will involve the roll-out of three strategically important initiatives: the agreement to support genetic testing for BRCA mutations in early breast cancer patients, the use of AI in screening for early lung cancer detection and establishing a research and development department in Serbia. Another recent and meaningful example is the early Chronic Kidney Disease diagnosis project that is happening in partnership with the Serbian society of nephrologists. Through it, based on lab data, GPs are receiving clear instructions how to guide and manage risk patients.
That’s correct. As a global leader, we at AstraZeneca understand our key role to play in addressing the biggest environmental challenges of our time. This is why we have a strong sustainability agenda focused on three major priorities: access to healthcare, environmental protection, and ethics and transparency. We are also following the UN’s Global Sustainable Development Goals and are committed to have a negative carbon footprint by 2030 through different initiatives, including planting 200 million trees under AZ Forest program across six continents by that time. In this regard, earlier this year it was announced that globally we will invest $400 million AZ Forest. Alongside Bulgaria, Croatia, Slovenia and Montenegro, Serbia is highly contributing to AZ Forest program and the trees planted on the territory of the Balkan cluster exceeds 10,000, which equals the absorption of avg. 250 000kg of CO2 per year. And by the end of this year, we will try to double that number.
To boost our ambitious sustainability agenda, a big number of initiatives are organized in Serbia and the Balkan Cluster, of which we are part. We are committed to have a fully electric fleet by 2025 and even though the infrastructure in our countries is quite challenging, I am very proud with the team’s motivation and drive to support this action. In addition, for more than two years we are supporting the bee population by adopting hives and helping local bee organizations. With our efforts till today half a million bees are protected, which pollinated over 1 billion plants. During this spring-summer season, our colleagues initiated cleaning initiatives through which more than 3000 L of garbage was collected.
Another program that is part of our sustainability agenda is Young Health Program. It aims at supporting young people to have a better understanding of the importance of a healthy lifestyle and habits. In Serbia we launched the program in 2021 with focus on smoking prevention among young people and as of this year we started series of initiatives that are building knowledge and prevention of obesity in early age. The program has also been approved by Ministry of Education and it is implemented as a project in selected elementary schools.
Last, but not least, we at AstraZeneca are also committed to driving the highest ethical standards and build ethical business culture, as well as ensuring inclusion and diversity and workforce safety and health.
TRANSFORMING HEALTHCARE IN SERBIA
Driving Progress in Serbian Healthcare with Cutting-Edge Solutions and International Cooperation
Sanja Radojević Škodrić, Director of the National Health Insurance Fund (RFZO), discusses the challenges and achievements of leading Serbia’s healthcare system, including innovations in treatments, investment in young medical professionals, and the importance of international collaborations.
SINCE 2017, 96 INNOVATIVE DRUGS HAVE BEEN ADDED TO THE LIST OF MEDICINES COVERED BY RFZO
SANJA RADOJEVIĆ ŠKODRIĆ Director of National Health Insurance Fund (RFZO)
You have been leading the National Health Insurance Fund (RFZO) since 2017. What have been the biggest challenges you’ve faced as the director of RFZO, and as a woman in medicine?
Being at the helm of the National Health Insurance Fund is in itself a demanding and challenging role, one that carries great trust but also a significant responsibility. Much was different seven years ago compared to today; things have improved in our healthcare system, with the largest investments in history across all segments of medicine, from innovative drugs to innovative methods. Without a doubt, the greatest challenge was the COVID-19 pandemic, and I believe everyone who was part of the healthcare system during that time, which bore the brunt of the pandemic, would agree with this assessment. It was the same in every country, but unlike many others who lacked protective equipment, masks, vaccines, and respirators, we had all of this, thanks in large part to the efforts of Serbia’s President, Aleksandar Vučić. We’ve almost forgotten how it all looked, how exhausting it was, but now, with the benefit of some time, I can say I am incredibly proud of how the entire healthcare system responded and was organised during that situation.
As for women in medicine, I believe the challenges are similar to those faced by women in other professions. Primarily, it involves balancing private and professional life, which
requires great support and understanding from family, and a lot of personal sacrifice. In medicine, men still dominate leadership positions, but this is changing, and now we have women in several important roles, including, as of recently, at the head of the Clinical Centre of Serbia. As the director of RFZO, I am pleased to highlight that the majority of employees at the Fund are women, and they are capable and skilled professionals dedicated to their work. The most important thing, of course, is whether someone performs their role well, not whether they are a man or a woman.
What would you highlight as your most important achievements as the director of the National Health Insurance Fund (RFZO)?
In recent years, progress has been made in various areas of healthcare, but I would highlight the most significant achievements of the National Health Insurance Fund as the consistent and stable supply of medicines, increased availability of innovative drugs, advancements in the treatment of rare dis-
SERBIA RANKS FIRST IN THE WORLD FOR STATE-FUNDED IN VITRO
FERTILISATION
(IVF) RIGHTS
eases, the expansion of rights to in vitro fertilisation (IVF), and the introduction of the human papillomavirus (HPV) vaccine. Apart from the COVID-19 pandemic, significant changes in the world over the past few years have also impacted the pharmaceutical market. Ensuring the supply of medicines was not easy. Many European countries faced long-term shortages of certain drugs. In our case, we did not face such problems; there were brief periods where specific drugs were unavailable, usually due to production, raw material, or transport issues. We managed to maintain regularity by reacting promptly, ensuring that all essential medicines were produced domestically, and diversifying imports from a wide range of manufacturers in different countries to avoid reliance on a single company.
When it comes to innovative drugs, which change the course and outcome of treatment and are therefore extremely expensive, investments in this type of therapy have been steadily increasing in recent years. As a result, new innovative drugs have been added to the list of medicines covered by RFZO. For example, since 2017, 96 innovative drugs have been added to the list, with an allocation of 16.2 billion dinars. Last year, 22 innovative drugs were added to the list, and the year before, 26, while between 2000 and 2012, only 49 innovative drugs were added over 12 years. Of course, it is not enough to just add a drug to the list; funds must be secured to ensure they remain available to patients for as long as needed. In 2023, the total value of innovative drugs amounted
FOR
THE BUDGET
RARE DISEASES HAS GROWN 55 TIMES SINCE 2012, IMPROVING TREATMENT
ACCESS FOR OVER 720 PATIENTS
to around 30 billion dinars, which is 7 billion more than the previous year and five times more than what was allocated 6-7 years ago.
There has also been tremendous progress in the treatment of rare diseases in recent years, greatly supported by the efforts of President Vučić and his wife Tamara. The budget for rare diseases was established in 2012 at the initiative of President Vučić and has since grown 55 times, from 130 million dinars to 7.2 billion dinars. As a result, the number of people receiving therapy at the state’s expense has risen from eight to more than 720, and the number of rare diseases covered has increased from two to 40 different rare diseases. It is important to note that only a small number of rare diseases have appropriate therapies. Before 2012, no investments were made in the treatment of rare diseases.
I would also like to highlight the expansion of statefunded rights to in vitro fertilisation (IVF), which has given many couples the chance to have the children they long for. Today, Serbia ranks first in the world in terms of state-funded IVF rights, according to experts. What was revolutionary regarding IVF in Serbia, despite some negative comments, was the introduction of procedures with donated reproductive material at the end of 2022, available not only to women with partners but also to women without partners.
Additionally, in June 2022, the HPV vaccine was introduced as the first innovative state-funded preventive medicine. It is particularly important that it was introduced for both genders, for boys and girls aged nine to 19. The effects of this will be seen in the coming years, once vaccination coverage becomes sufficiently high.
You had the opportunity to visit the AICA pharmaceutical factory in Cuba. Can you tell us more about this collaboration and what it represents for healthcare in Serbia?
Together with Minister Jelena Begović, I was on a working visit to Havana. In discussions with the Cuban Minister of Science and representatives of their pharmaceutical companies, we learned about the innovative biological medicines for which Cuba is renowned worldwide. I visited the BioCubaFarma pharmaceutical factory, which focuses on the development and production of vaccines, biological medicines, and other pharmaceutical products that have contributed to the improvement of Cuba’s healthcare system. I also toured a generic medicine factory. Their medicines are in various stages of clinical trials across the globe, and so far, they have developed more than 900 products, mainly in the fields of medicine and biomedicine. These include a hepatitis B vaccine, which they also export, and they are working on products related to diabetes, cancer, and arthritis. We also discussed the possibilities of collaboration between their institutions and ours, and I hope that this will be realised in the future.
In the past, you mentioned that prevention in healthcare is the most expensive, but in the long term, it is the most cost-effective. Could you share which screenings are conducted in healthcare institutions with the aim of early disease detection?
Prevention is a focus of the most developed countries. Investment in prevention is, in fact, the most expensive investment, but our healthcare policy is that health has no price. Early diagnosis, as part of prevention, is crucial for a positive treatment outcome. People in Serbia are slowly starting to realise this, and they are visiting doctors not only when they have a problem but also to check their health when they have no symptoms. We hope this mindset will fully take root, as preventive examinations are one of the main priorities of the new government’s healthcare policy.
In Serbia, screenings covered by the RFZO include early detection of depression, colorectal cancer, type 2 diabetes, breast cancer, cervical cancer, and cardiovascular risk. These tests are conducted in primary healthcare facilities, with all positive results referred to secondary and tertiary institutions for further evaluation.
In addition to adult screenings, several tests are performed for rare diseases in newborns, including for phenylketonuria, hypothyroidism, cystic fibrosis, and spinal muscular atrophy (SMA). Screening for cystic fibrosis was introduced in 2021, and for SMA in September last year. Serbia is one of the few countries where this screening is mandatory. The goal is to diagnose as early as possible so treatment can begin before symptoms appear, as in the past, a lot of time was lost in establishing the diagnosis.
Recently, RFZO concluded a framework agreement for the procurement of drugs to treat two rare diseases in children, ‘butterfly children’ and eosinophilic esophagitis. How important is this therapy for those facing these rare diseases?
These drugs are of immense importance due to the nature of the two rare diseases, epidermolysis bullosa and eosinophilic esophagitis. Epidermolysis bullosa, or ‘butterfly children,’ is a condition where children endure constant pain, with an increased risk of infections and other complications. For the
second disease, eosinophilic esophagitis, which three children are receiving treatment for, patients cannot eat normally, suffer from frequent vomiting, have difficulty swallowing, and face other oesophageal problems. This not only disrupts the life of the patient but also the entire family, as rare diseases affect the functioning of the whole family.
COLLABORATION WITH CUBA OPENS DOORS TO CUTTINGEDGE TREATMENTS AND PHARMACEUTICAL
ADVANCEMENTS FOR SERBIAN HEALTHCARE
There was no treatment for ‘butterfly children’ until May of last year when a gene therapy cream was approved in the US. Its goal is to alleviate the patient’s pain, reduce skin wounds, and mitigate the effects of the disease to make daily life easier for the patient. This cream costs around 600,000 euros per patient per year, depending on the patient’s condition and the surface area of the skin being treated. It is only suitable for one type of epidermolysis bullosa, meaning not all patients can use it. Only nine countries worldwide have secured access to this medication, and Serbia is among them, thanks to the significant support and initiative of Serbian President Aleksandar Vučić.
Two girls have already received the therapy, and it has been approved for six more patients selected by medical experts. No country can fund treatment for all patients at once. So far, France, Germany, Norway, and Italy have treated a total of 14 patients.
Are there any programmes or initiatives that involve investment in young medical professionals?
The state places great emphasis on young doctors and is doing everything it can to provide them with opportunities for further training, so that one day they can lead the healthcare system and remain in the country where they were educated. Since 2018, there has been a programme for employing the best graduates from medical faculties and high school medical graduates. So far, 1,640 doctors and 2,000 top nurses and technicians have been employed in public healthcare institutions through this programme.
Do you have any advice for young people who want to pursue a career in healthcare in Serbia?
Helping people, healing them, and being involved in the arrival of a new life into the world is one of the most noble and beautiful vocations. On the other hand, it requires great dedication, learning, and effort, which not everyone is equally ready for. Don’t forget that medical studies last longer than other degree programmes, and the job requires ongoing professional development. You are in service to your patients even on weekends and holidays. Those who want to be doctors should first have a deep love for this profession and should never forget why they chose medicine and how human and meaningful the work is. As the director of RFZO, I am always proud to highlight that our health insurance is one of the few in the world based on solidarity and humanity.
BUILDING A RESILIENT FUTURE STARTS WITH PRIORITIZING MENTAL HEALTH
DEYANA KOSTADINOVA Director of UNICEF in Serbia
At the third Conference on Mental Health in Serbia, Deyana Kostadinova, the UNICEF Representative, delivered a powerful speech calling for urgent attention to the mental health needs of children and young people. In her address to a distinguished audience that included highranking officials such as Minister Lončar, Professor Djukić Dejanović, Minister Žigmanov, and Minister Stamenkovski, Kostadinova emphasized the importance of creating safe and supportive environments for the younger generation.
Kostadinova began by acknowledging the many hidden struggles young people face, referencing the story of Milica, a young person whose challenges were recently shared. She stressed that, for every child who has the courage to seek help, many others suffer in silence. “As a parent, I see myself in Milica’s mother, and I’m sure many of you do as well. We must not ignore what we cannot see,” she said, calling for a unified effort to address the mental health needs of not only children but also parents, caregivers, and professionals who support them.
She highlighted the broader societal implications of mental health, emphasizing that investing in the well-being of children today ensures a thriving, resilient society tomor-
UNICEF’s Deyana Kostadinova Calls for Greater Investment in Mental Health at Conference
row. “Every euro invested in mental health brings economic benefits many times over, reducing healthcare costs, school dropouts, crime rates, and increasing productivity,” Kostadinova said. She underscored that mental health care is essential, not optional, for building a society capable of facing future challenges.
Kostadinova applauded Serbia’s leadership on this issue, noting the memorandum of understanding signed by six ministries, led by the Ministry of Health, as a significant step in building a foundation for mental health services. She also praised the collaboration with international partners, such as the World Health Organization, which has provided valuable guidance and expertise in these efforts.
In her speech, Kostadinova pointed to the importance of expanding community-based mental health services, especially in the wake of the Ribnikar School tragedy last year, which underscored the critical need for mental health care for all children. She called for continued efforts to provide safe spaces, such as youth centers, where young people can express themselves and seek help.
INVESTING IN MENTAL HEALTH IS ESSENTIAL, NOT OPTIONAL
Finally, Kostadinova emphasized that the government alone cannot achieve this vision. She called for a joint effort involving government, civil society, communities, and academia, highlighting the importance of partnerships. She expressed gratitude to key partners, including the embassies of Norway, Australia, and Israel, as well as corporate partners like Delhaize and the Electric Power Industry of Serbia, whose contributions are vital to improving mental health services for young people.
In closing, Kostadinova expressed hope for the future, calling for courage, energy, and partnership to continue making progress. “Together, we can create lasting change for young people, and today is about reaffirming our commitment to that journey,” she said.
BLAŽO PISARIĆ Founder and CEO of the Audio BM Group
DTHE HAPPINESS OF OUR CLIENTS IS OUR SATISFACTION
Bringing Sound to Life with Advancements at Audio BM Group
o you have an estimate of how much of the population has hearing problems?
Statistics in Europe and in our region are quite similar, and they show that every 10th person has some form of hearing impairment, with a third of these individuals requiring hearing aids or some other form of treatment.
Many hearing problems, like tinnitus, are often a consequence of other illnesses, but the true cause cannot always be determined. How does your centre help in diagnosing these issues?
Modern life, full of activity and stress, is increasingly leaving its mark on people’s hearing. As a result, hearing disorders with unknown causes are not uncommon, one of which is tinnitus, or ringing in the ears. Our centre is equipped with comprehensive, state-of-the-art diagnostics for determining the degree and type of hearing impairment, allowing us to act clearly and precisely towards a solution. In specialised rooms where various life situations can be simulated, patients can try out all the hearing solutions offered by the world’s most renowned manufacturers. Additionally, at “World of Hearing,” we offer products aimed at preventing and preserving hearing health, such as custommade earplugs for noise protection or water protection.
How do your patients accept hearing aids? Do you offer psychological support alongside technical assistance?
For a long time, hearing aids were stigmatised in society. Today, with advances in technology and a proper approach, hearing aids are products that users are extremely satisfied with. Of course, the psychological approach of our acousticians and defectologists is essential, as well as appropriately addressing the issue with patients and their companions. In most cases, children with hearing impairments come to our centre accompanied by their parents, and elderly people are accompanied by caregivers. At “World of Hearing,” with just a few clicks on the computer, the patient’s companion can experience exactly what the patient is hearing, and together, with the advice and help of our defectologists, they can choose the best and most comfortable hearing aid to suit the patient’s needs and hearing status.
This approach is only available in our centre in Serbia, and the results are truly impressive. “World of Hearing” is a unique
hearing centre in Serbia and the only one in the Balkans, and our company is preparing to open a similar centre in Belgrade next spring.
New technologies are emerging rapidly. How does this affect the development of hearing aids, and what is currently “state of the art” in this field?
The world of hearing aids keeps up with the development of new technologies. The latest hearing aids are both design and technical marvels. They are almost invisible and can flawlessly communicate with all devices that are part of our daily lives, such as mobile phones and smart TVs, and increasingly, artificial intelligence is guiding their operation.
From your work, I would highlight your success with completely deaf individuals. There is information that you have introduced over 600 people from the world of silence into the world of hearing. How did you achieve this, and with which technology?
Thanks to modern implants for the middle or inner ear, as well as the aforementioned hearing aids, everyone can hear today. It’s true that 600 of these completely deaf individuals, most of whom are children, have received inner ear implants and can now hear and speak normally.
I would like to take this opportunity, on behalf of these 600 implanted individuals, to especially thank the Ministry of Health of the Republic of Serbia and the Republic Health Insurance Fund, without whose help these people would not have experienced the beauty of hearing.
Lift&learn
JOINT EFFORTS TO STRENGTHEN SUPPORT SYSTEMS
Third International Conference on the Mental Health and Well-Being of Children and Youth
The establishment of a Working Group for the Protection of Children’s and Youths’ Mental Health and the development of an Action Plan with clearly defined responsibilities across sectors are some of the results of a year-long implementation of the Memorandum of Understanding signed by six ministries. Progress has also been made at the local level, where cooperation among institutions in five cities and municipalities is leading to the development of local cooperation protocols, ensuring better support for children, youth, and parents. This was highlighted at the Third International Conference on Mental Health and Psychosocial Support for Children and Youth.
In his address, Minister of Health Zlatibor Lončar emphasized that the mental health of children is the foundation upon which the future is built. “The Government of the Republic of Serbia and the Ministry of Health, with the support of all relevant ministries, are committed to improving systemic care for the mental health of children, youth, and parents. Together, we are using all available resources to provide quality support, especially for the most vulnerable children and youth. This step represents an important move forward in reforming and improving the support system for mental health in our country. A healthy Serbia is our shared goal, and healthy children
are our greatest and most important investment in the future,” said Minister Lončar.
Ahead of World Mental Health Day on 10 October, the Third International Conference brought together experts and professionals from education, healthcare, social protection, and youth organizations. The conference also marked one year since the signing of the Memorandum of Understanding by six ministries: the Ministry of Health, Ministry of Education, Ministry of Tourism and Youth, Ministry of Labour, Employment, Veteran and Social Affairs, Ministry of Human and Minority Rights and Social Dialogue, and the Ministry of Family Care and Demography.
Deyana Kostadinova, Director of UNICEF in Serbia, highlighted the importance of providing continuous psychological
EARLY INTERVENTION IN MENTAL HEALTH CAN SIGNIFICANTLY REDUCE NEGATIVE OUTCOMES LIKE CRIME, SUBSTANCE ABUSE, AND SCHOOL DROPOUTS, CREATING A HEALTHIER, MORE PRODUCTIVE SOCIETY
and emotional support to children and young people. “The healthy development of youth represents Serbia’s future. Every child and young person must have access to services that support mental health. Early intervention is a wise investment—it strengthens Serbia’s economic resilience and ensures long-term sustainable growth. If we act now, we can reduce negative outcomes such as crime, substance abuse, and early school dropout. At the same time, we can build a healthier and more productive society. This conference is crucial as it fosters the partnerships needed to take joint responsibility for the mental well-being of youth, including collaboration with ministries, the corporate sector, and other key partners,” said Deyana Kostadinova.
Prof. Dr. Fabio Skano, Director of the World Health Organization (WHO) in Serbia and Special Envoy of the WHO Regional Director for the Western Balkans, emphasized the significance of mental health for the future of society. “Our role as parents and teachers is to encourage open conversations about mental health and to urge young people to seek help when needed. It’s not enough just to seek understanding; it’s important to offer it as well. By prioritizing young people’s mental health, we are investing in a brighter, healthier future for all. Together, with collective efforts, we can make a significant difference in the lives of young people,” said Dr. Fabio Skano.
During the conference, both national and international examples of good practice were presented. Of particular interest was the Minimal Service Package for Youth, developed in collaboration with the Institute of Mental Health, which has the potential to significantly improve the availability and quality of services at the local level.
Džana Numanović, a representative of the UNICEF Youth Board, spoke about the importance of services that meet the needs of
A
young people. “We need easily accessible mental health services and information tailored to different groups of children and young people—those from the general population and those who are often neglected, such as children and young people from the Roma community or those with developmental disabilities. If professional support becomes standard, if we normalize seeking help, and if we use online platforms for accessible and anonymous support, we can help overcome stigma and change how we talk about mental health,” said Džana Numanović.
Respecting the rights of children and youth to good mental health and well-being is key to realizing all their other rights. Only through joint efforts can we ensure that the mental health of children, adolescents, and caregivers becomes a priority in every family, school, workplace, and community. This was the key message of this year’s conference.
HEALTHY SERBIA DEPENDS
ON PRIORITIZING THE MENTAL HEALTH OF CHILDREN AS THE FOUNDATION FOR THE FUTURE
Zlatibor Lončar
Deyana Konstadinova
International Ophthalmology Symposium in Belgrade: INNOVATIONS IN OPHTHALMOLOGY AND ADVANCING CHILDREN’S TREATMENT
Global Experts Gather in Belgrade to Improve Children’s Eye Treatment
Belgrade recently was the gathering place for leading global experts in the field of ophthalmology, thanks to the International Ophthalmology Symposium organised by the MediGroup system and the Miloš Clinic. This exceptional event brought together over 600 eminent ophthalmologists from Serbia, the region, and around the world, with a particular focus on pediatric ophthalmology and strabology.
The symposium, held in the Serbian capital, provided a unique opportunity for specialists to exchange knowledge and experiences. Doctors from various countries had the chance to expand their understanding of the latest techniques in diagnosing and treating eye conditions in children – the most vulnerable patients who require special attention and expertise.
Focus on PEDIATRIC Ophthalmology and Strabismus
One of the main goals of this year’s symposium was to improve treatment methods for strabismus, a condition affecting a large number of children worldwide. Participants had the opportunity to hear lectures and engage in discussions on the latest technological advancements in eye surgery, with a particular focus on pediatric ophthalmology.
OVER 600 OPHTHALMOLOGISTS FROM AROUND THE WORLD GATHERED IN BELGRADE TO FOCUS ON PAEDIATRIC EYE CARE
DR.
KENNETH
W. WRIGHT SHOWCASED THE LATEST TECHNIQUES IN
TREATING STRABISMUS IN CHILDREN
Among the leading speakers was Dr. Kenneth W. Wright, one of the world’s most renowned experts in pediatric ophthalmology. Dr. Wright, from Los Angeles, presented the latest techniques in the surgical treatment of strabismus, including complex procedures performed on the youngest patients. His participation was of great significance, as Dr. Wright has been a leading figure in this field for decades, with extensive experience in working with children with strabismus, including infants diagnosed with cataracts.
Expertise and Experience in Action
As part of the symposium, Dr. Wright conducted a special educational workshop for local ophthalmologists, during which he demonstrated a surgical procedure for the correction of strabismus. This workshop provided local specialists with insight into the latest surgical techniques and allowed them to witness first-hand the treatment of some of the most complex cases of strabismus and other eye conditions in children.
“Imagine a child with crossed eyes or an infant with cataracts. It is important to act quickly and operate immediately to avoid complications. I once performed cataract surgery on a baby who was just two days old,” Dr. Wright emphasised during his lecture. This statement highlights the urgency of timely interventions in pediatric ophthalmology, as early procedures significantly improve the chances of successful recovery.
Significance for the Miloš Clinic and the Ophthalmology Community
For the Miloš Clinic and the MediGroup system, the symposium marked another important step in strengthening their position as leaders in ophthalmology, both in Serbia and the region. Organising such a prestigious event in collaboration with international experts underscores the clinic’s commitment to advancing medical practices through innovation and education.
“We are proud to host this event and to welcome some of the world’s greatest experts in ophthalmology. Our dedication to improving medical practices and providing the best possible care for patients is why we constantly invest in education and international collaboration,” said Marijana Vasilesku, CEO of MediGroup.
Strengthening the Professional Community
The International Ophthalmology Symposium, with over 600 participants and leading global experts such as Dr. Wright, provided a unique opportunity for doctors from Serbia and the region to enhance their knowledge, adopt new techniques, and achieve better results in treating children with eye diseases. This event strengthened the professional community and opened doors for further collaboration and knowledge exchange, reaffirming Belgrade as an important centre for medical innovation.
WORLD-CLASS AESTHETIC AND RECONSTRUCTIVE SURGERY
DR. SPEC. MED. TANJA RADENKOV MEDENICA
Eterna Medical System & Hospital
Founder and owner of Eterna Medical System, which includes Eterna Polyclinic and Eterna Hospital, a specialised hospital for plastic, aesthetic, and reconstructive surgery
Your hospital is specialised in aesthetic and reconstructive surgery. The public often associates this with cosmetic treatments, but what does it really entail, and how serious is this field of medicine?
Eterna Hospital is a specialised hospital for plastic, aesthetic, and reconstructive surgery, and within our polyclinic, we also offer anti-ageing procedures, as well as consultations with general practitioners and ENT specialists. Plastic and reconstructive surgery does not only involve cosmetic enhancements but also addresses and treats very complex medical conditions, such as burns, and the reconstruction of congenital and acquired facial and body anomalies.
You apply numerous innovative methods. What are you proud of? Is it perhaps the hair transplant method?
Eterna is among the pioneers of hair transplantation in Serbia. We have been performing this procedure for ten years, and we have thousands of satisfied patients not only from Serbia but from around the world. When you approach something with thoroughness, responsibility, and dedication, while continually striving for improvement, quality and success are inevitable.
Eterna Hospital’s Expertise and Innovation
You are also known for your top-tier anti-ageing treatments. What do they involve, and who opts for them?
I believe that a person continues to learn throughout their life. I regularly attend and lecture at all major global congresses on aesthetic and anti-ageing medicine. As a result, here at Eterna, we are always the first to bring global beauty trends. These treatments appeal to everyone who wants to nurture their natural beauty or correct imperfections. Their popularity is growing because they don’t require lengthy recovery periods, results are visible almost immediately, and the effects are easily maintained for long-lasting results. The most popular treatments remain hyaluronic fillers and Botox, but with the increasing demand for non-surgical procedures that deliver excellent results, thread face-lifting, combined with skin quality treatments, is one of the most sought-after procedures, giving results closest to surgical lifting. Additionally, laser treatments for skin tightening on the face and body, as well as radiofrequency treatments, are highly in demand.
Is there an anti-ageing treatment package, and is one treatment enough, or is it necessary to have multiple procedures?
The best approach is to treat the face as a whole. In this way, we can easily identify what should be highlighted and what might need correcting or concealing. The best effects come from combining treatments, which we tailor individually for each patient according to their desired effect and the current condition of their skin.
Why should patients choose your hospital? How do you differ from others?
I would never focus on how we differ from others because being different doesn’t always mean being better. What drives me in my work is a constant desire for progress and learning, dedication to my patients, a professional approach, responsibility towards the patient, and, above all, prioritising health.
Aesthetic surgery services in Serbia are of the highest standard, yet significantly more affordable than in the West. Is there demand from foreign patients, and to what extent do they make up your clientele?
Our patients come from all corners of the world, and this doesn’t necessarily mean that the reason is the lower cost of procedures. Patients come for the quality and credibility of the doctors and the institution in which they work. Serbia has excellent plastic surgeons whose expertise and knowledge attract patients from around the world.
PROVEN HAIR CARE SOLUTIONS FOR HAIR LOSS AND DANDRUFF
Swiss Expertise in Hair Care: Combat Hair Loss and Dandruff with Clinically Proven Products
Revalid®, a Swiss brand with a 30-year tradition of quality, provides everything your hair needs.
Whether you’re experiencing hair loss or dandruff, Revalid® is the solution. Its effectiveness has been proven by clinical studies, numerous satisfied users, and high customer loyalty.
The Revalid® Anti-Hair Loss line includes external care products – Revalid® Men’s and Women’s Shampoo and Serum, as well as capsules that support your hair from within. By regularly using these products in combination, your hair will gain 28,000 new strands after three months.
Recently, the well-known range has been expanded to include the Revalid® Anti-Dandruff line. Whether you’re battling severe dandruff, seborrheic dermatitis, or mild dandruff, the Revalid® Anti-Dandruff line is your strongest ally.
Revalid® Triple Active Shampoo DS, with clinically proven effectiveness, is used during the acute phase for seborrheic dermatitis
and severe, persistent dandruff. This exceptionally gentle shampoo, with powerful active anti-dandruff ingredients, cleanses the scalp gently, without causing irritation during or after use. Revalid® Triple Active Shampoo DS maintains a healthy scalp microbiome and delivers quick, long-lasting results – up to 99% less dandruff and 83% less itchiness. Daily use is recommended for four weeks.
After using Revalid® Triple Active Shampoo DS, it is recommended to switch to Revalid® Anti-Dandruff Shampoo for daily use during the maintenance phase. This shampoo can also be used for mild to moderate dandruff. Its active ingredients restore the scalp’s natural moisture balance and prevent the formation of new flakes. The shampoo soothes the scalp and reduces unpleasant itching.
All Revalid® products are dermatologically tested, free from parabens, silicones, and sulphates, and meet the highest quality standards to offer the best hair care solutions. Enjoy healthy, radiant, and strong hair with Revalid® products.
BY REGULARLY USING REVALID® PRODUCTS, YOUR HAIR WILL GAIN 28,000 NEW STRANDS AFTER JUST THREE MONTHS
TWO DECADES OF FIGHTING FOR DIGNITY
BELhospice Marks World Hospice and Palliative Care Day
DR
ALEKSANDRA MARJANOVIĆ
BELhopsice director
This year, World Hospice and Palliative Care Day was marked on 12th October across the globe under the theme: “Ten Years Since the Resolution: Where Are We Now?”
The BELhospice centre will join the global initiative with a series of activities aimed at raising awareness about the importance of palliative care – an approach that improves the quality of life for patients facing incurable illnesses, as well as their families.
“Through public presence, lectures, the promotion of the ‘Palliative Care Manual for Nurses’, and educational content on social media, we will strive to inform citizens about palliative care, their rights, and access to these services. BELhospice is a specialised charity that has been providing free palliative care to patients with progressive and incurable oncological diseas-
es, as well as children with severe and life-limiting illnesses, and their families for two decades. This includes help and support in coping with the illness and its consequences, encompassing adjustment to the new situation, social functioning, improving relationships and communication within the family, and providing psychological support for various emotional states. BELhospice also offers spiritual support, helping address questions and dilemmas related to the meaning of illness, suffering, and death. Our work is therefore vital for those who need care and support in the most sensitive moments of life, and we are solely funded through donations raised via charity events and the help of Serbian citizens,” said Dr. Aleksandra Marjanović, Director of the BELhospice centre, adding: “That’s why it is extremely important to talk about this issue continuously, wherever possible, including through the media, so that more citizens know they are not, and do not have to be, alone during the most difficult times in life. Palliative care is the right of every person to a dignified life without pain and suffering.”
According to available data, in the last decade, the first steps necessary for the development of palliative care in Serbia have been made, but unfortunately, it is still only available to a limited number of patients. There is still a lack of clear
PALLIATIVE CARE IS THE RIGHT OF EVERY PERSON TO A DIGNIFIED LIFE WITHOUT PAIN AND SUFFERING
THE NEED FOR PALLIATIVE CARE CONTINUES TO GROW
According to research conducted by WHPCA and WHO, it is estimated that more than 60 million people require palliative care each year, including 31.1 million in the earlier stages and 25.7 million towards the end of life.
The majority (67%) are adults over the age of 50, and at least 7% are children. Most (54%) are patients who are not in their final year of life but still require palliative care.
The burden of serious illnesses, health-related suffering, and the need for palliative care is immense. However, palliative care remains unavailable to most people in need, especially in low- and middle-income countries.
BELHOSPICE PROVIDES FREE PALLIATIVE CARE FOR PATIENTS WITH CANCER AND SEVERE ILLNESSES, AS WELL AS SUPPORT FOR THEIR FAMILIES
understanding, both among professionals and the public, about what palliative care truly encompasses and how it can improve the quality of life for patients and their families.
Data from 2023 shows that a significant number of patients in Serbia require palliative care, especially oncology patients. Around 75% of oncology patients experience pain at some stage of the disease, which is one of the main symptoms treated within palliative care. Estimates suggest that the number of people in need of palliative care is much higher than current capacities can cover, and this applies not only to oncology patients but also to those with other chronic, severe, and incurable diseases.
“These may include malignant, cardiovascular, respiratory, neurological, and other diseases. The goal of this approach is to improve the quality of life for both patients and their families – less suffering and more dignity. An
BELHOSPICE CENTRE SERVICES
BELhospice provides free palliative care for two groups of patients: adults and the elderly suffering from cancer, as well as children and young people with severe illnesses. In addition to caring for patients, we also offer support to their families. Palliative care involves preventing and alleviating suffering through the early identification and treatment of various symptoms – physical, psychological, social, and spiritual. Our team consists of experts from various fields who work together to provide comprehensive support to patients. Services are available every weekday from 8 am to 4 pm. We collaborate with healthcare and social institutions, and family support is an integral part of our care. Palliative care supports the treatment of illnesses and helps both patients and their families cope with challenging times.
important aspect of the support we provide to our users is the provision of aids that can greatly help both the patient and the family, such as anti-decubitus mattresses, toilet and wheelchair chairs, hospital beds, and more. Over the past two years, BELhospice has also been caring for children with severe and life-limiting illnesses,” said Dr. Gordana Simić, a member of the BELhospice multidisciplinary team.
Regarding oncology patients, according to data from multiple sources, a large number end up being treated at home, where they are often left in the care of their families or nongovernmental organisations like BELhospice, which provides palliative care. However, in residential facilities such as care homes, more than 60% of users also require this type of care. The key challenges in palliative care are recognised in the lack of capacity, as well as a shortage of specialised staff.
For now, BELhospice primarily provides support at home or in care homes within the Belgrade area. In addition, Dr. Simić highlights that there is also the possibility of telephone consultations to assist patients outside the Belgrade area.
Provision of medical aids for use
BELhospice care
79 YEARS OF GALENIKA:
THE SUCCESS OF ALL EMPLOYEES
Excellence and Innovation: Galenika’s Legacy and Commitment to the Future
The company’s anniversary carries a strong message of unity and team spirit across all sectors of Galenika – “A lasting success, people who matter.”
With 79 years of expertise, Galenika is among the oldest pharmaceutical companies in the region still in operation, and one of the oldest in Europe, and a company always focused on the future. The “lasting success” refers to this important milestone.
Decades of accumulated knowledge and experience demonstrate the success of Galenika’s mission of health, continuously focusing on the current and future healthcare needs of patients and consumers.
who work at Galenika today, and those who worked in the past, have contributed to its growth and importance. Times change, but our people are and will remain our strength,” said Ricardo Vian Marques, General Manager of Galenika.
The company employs up to 100 educational profiles working across more than 70 units, and as much as 63% of leadership positions are held by women. About 20% of employees have been with Galenika for over 25 years, and more than 10 languages are spoken across the three continents on which the company operates.
The “company of experts,” as it is known, has come a long way since its founding in 1945, starting with basic production, expanding first in the territory of the former Yugoslavia and then beyond, even outside Europe. Today, Galenika holds a strong regional position, continually investing in people, equipment, digitalisation, and expanding its portfolio with modern and effective products.
Galenika was named after Galen, the father of scientific pharmacy, and today is part of Brazil’s NC Group, which also includes EMS – the largest pharmaceutical company in Brazil and one of the largest in Latin America. With a portfolio of more than 280 products, Galenika produces the most advanced generic medicines, dietary supplements, cosmetic products, medical devices, and general-use items. The brand is recognised for its unique tradition and top quality, making it a true “love brand” in the region.
“This year we celebrated 79 years, and that is the success of the entire team. There are many drug manufacturers, and people often don’t know their names, even when they use some of their products. With us, it’s different. Our patients and consumers recognise the brand and know that Galenika is a guarantee of top quality. All the employees
WITH 79 YEARS OF EXPERTISE, GALENIKA IS AMONG THE OLDEST PHARMACEUTICAL COMPANIES IN THE REGION STILL IN OPERATION, AND ONE OF THE OLDEST IN EUROPE
“We strive, together and with dedication, to continuously improve people’s lives through research and development, education, technology, networking, and community investment. Every day, our pharmaceutical products, so small they fit in the palm of your hand, have a huge impact because they help people recover, feel better, and live healthier and better lives. Being part of this ongoing miracle is a true calling. I am proud of the team and grateful to everyone who works diligently every day to bring about positive changes,” added Ricardo Vian Marques, General Manager of Galenika.
RICARDO VIAN MARQUES
General manager of the Galenika
